Contrast Media Agent and Injector System Market - A Global and Regional Analysis: Focus on Product and Country Analysis - Analysis and Forecast, 2022-2026

Report
183 Pages
June 2023
Region: Global
BIS Research
ID: 5830856

IT Advances in Contrast Media Injectors Present Market Opportunities

The global contrast media agent and injector system market was valued at $7.63 billion in 2022 and is expected to reach $9.71 billion by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026. The market is driven by factors such as the increasing prevalence of cancer and cardiovascular diseases leading to an upsurge in demand for imaging with contrast media agent and injector system and image-guided diagnostics.

Market Lifecycle Stage

The global contrast media agent and injector system market is developing. The global contrast media agent and injector system market has witnessed several collaborations among the market players. The collaborations are aimed at combining capabilities, expanding the customer base, and marketing, among others.

The opportunity for growth of the global contrast media agent and injector system market lies in continued research and development activities for manufacturing innovative contrast media agent and injector system. Many pharmaceutical companies are expanding their businesses and becoming more outsourcing-oriented.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the world's healthcare sector, especially the contrast media agent and injector system sector. The COVID-19 pandemic led to the rescheduling of non-essential diagnostic tests and treatment procedures in order to allocate more resources toward the management of COVID-19. The American College of Radiology postponed non-urgent outpatient visits in accordance with the guidelines put forth by the Centers for Disease Control and Preventio (CDC). According to a paper published in the Radiological Society of North America (RSNA) in April 2020, titled ‘The Economic Impact of the COVID-19 Pandemic on Radiology Practices,’ imaging volumes were affected with the greatest decline observed in outpatient settings, followed by emergency departments and inpatient settings.

The future impact of COVID-19 on the demand and supply across the global contrast media agent and injector system market depends on the abilities of stakeholders to withstand unforeseeable scenarios in the future. The intensity of impact due to COVID-19 in the future will depend on the current efforts being made by companies to equip their supply chains with the necessary components and processes to remain responsive.

Market Segmentation

Segmentation 1: by Product

Contrast Media Agents
Injector Systems

The global contrast media agent and injector system market (by product) is expected to be dominated by the contrast media agents segment.

Segmentation: Contrast Media Agents (by Modality)

X-Ray/CT Scan
MRI
Ultrasound

The global contrast media agent market (by modality) is expected to be dominated by the X-Ray/CT scan.

Segmentation: Contrast Media Agents (by Type of Media Agent)

Iodine-Based Contrast Media Agent
Gadolinium-Based Contrast Media Agent
Barium-Based Contrast Media Agent
Microbubble Contrast Media Agent
Others

The global contrast media agent market (by type of media agent) is expected to be dominated by iodine-based contrast media agent.

Segmentation: Injector Systems (by Modality)

CT Injector Systems
MRI Injector Systems
Cardiovascular/Angiography Injector Systems

The global contrast media injector system market (by modality) is expected to be dominated by CT injector systems.

Segmentation: Injector Systems (by Product)

Injector
Consumables and Accessories

The global contrast media injector system market (by product) is expected to be dominated by consumables and accessories.

Segmentation: Injector Systems (by Injector Type)

Single-Head Injectors
Dual-Head Injectors
Syringeless Injectors

The global contrast media injector system market (by injector type) is expected to be dominated by single-head injectors.

Segmentation 2: by Region

North America - U.S., Canada
Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe
Asia-Pacific - China, Japan, India, Australia, and Rest-of-Asia-Pacific
Rest-of-the-World

The global contrast media agent and injector system market (by region) is dominated by the North America region.

Recent Developments in Global Contrast Media Agent and Injector System Market

In January 2023, Bayer AG received approval in Europe for its Ultravist-300, -370, an iodine-based contrast agent for contrast-enhanced mammography (CEM).
In December 2022, Beijing Beilu Pharmaceutical Co. Ltd. expanded its business by establishing a wholly-owned subsidiary in Hong Kong.
In April 2022, Beijing Beilu Pharmaceutical Co., Ltd.’s gadobutrol injection received the "Drug Registration Certificate" from the National Medial Production Administration (NMPA).
In February 2023, Bracco Group partnered with Wellstar Health System. Through this partnership, the company conducted trials for its FDA-approved VUEWAY (gadopiclenol) injection, which is a contrast agent for use in MRI.
In February 2023, Bracco Group acquired all the shares of Bracco-Eisai from Eisai. Furthermore, the company also changed the name of the company from Bracco-Eisai to Bracco Japan, Ltd.
In July 2022, Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA, launched its range of generic contrast media agents’ generics in the U.S.
In December 2022, General Electric Company partnered with ulrich GmbH & Co. KG. Through this partnership, the companies aimed to offer a branded multi-dose contrast media injector in the U.S.

Demand - Drivers and Limitations

The following are the drivers for the global contrast media agent and injector system market:

Increasing prevalence of cancer and cardiovascular diseases leading to an upsurge in demand for imaging with contrast media agent and injector system
Upsurge in demand for image-guided diagnostics
Growing number of regulatory approvals

The market is expected to face some limitations as well due to the following challenges:

Rising health concerns post usage of contrast media agents in the body

How can this report add value to an organization?

Growth/Marketing Strategy: The global contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
Competitive Strategy: The global contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies have the opportunity to expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled

Bayer AG
Beijing Beilu Pharmaceutical Co. Ltd.
Bracco Group
Fresenius SE & Co. KGaA
FUJIFILM Holdings Corporation
General Electric Company
Guerbet
Jiangsu Hengrui Pharmaceutical Co. Ltd.
Jodas Expoim Pvt. Ltd.
Lantheus Holdings, Inc.
Shenzen Seacrown Electromechanical Co. Ltd.
Sino Medical-Device Technology Co. Ltd.
ulrich GmbH & Co. KG
Unijules Life Sciences Ltd.

1 Markets

1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.2 Market Overview
1.3 Industry Outlook
1.3.1 Regulatory and Legal Requirements and Framework
1.3.1.1 Regulatory and Legal Requirements and Framework in the U.S.
1.3.1.2 Regulatory and Legal Requirements and Framework in Europe
1.3.1.3 Regulatory and Legal Requirements and Framework in Asia-Pacific
1.3.1.3.1 China
1.3.1.3.2 Japan
1.3.2 Patent Analysis
1.3.2.1 Patent Filing Trend (by Year)
1.3.2.2 Patent Filing Trend (by Country)
1.3.3 Key Trends
1.3.3.1 Nanoparticle-Based Contrast Agents
1.3.3.2 Development of Safer Contrast Media Agent
1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
1.4.1 Pre-COVID-19 Impact
1.4.2 During COVID-19 Impact
1.4.3 Post-COVID-19 Impact
1.5 Market Dynamics
1.5.1 Impact Analysis
1.5.2 Market Drivers
1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
1.5.2.3 Growing Number of Regulatory Approvals
1.5.3 Market Restraints
1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
1.5.4 Market Opportunities
1.5.4.1 IT Advances in Contrast Media Injectors

2 Product

2.1 Overview
2.2 Growth-Share Matrix
2.3 Contrast Media Agents
2.3.1 Market Dynamics
2.3.2 Market Size and Forecast
2.3.2.1 By Modality
2.3.2.1.1 X-Ray/CT Scan
2.3.2.1.2 MRI
2.3.2.1.3 Ultrasound
2.3.2.2 By Type of Media Agent
2.3.2.2.1 Iodine-Based Contrast Media Agent
2.3.2.2.2 Gadolinium-Based Contrast Media Agent
2.3.2.2.3 Barium-Based Contrast Media Agent
2.3.2.2.4 Microbubble Contrast Media Agent
2.3.2.2.5 Others
2.4 Injector Systems
2.4.1 Market Dynamics
2.4.2 Market Size and Forecast
2.4.2.1 By Product
2.4.2.1.1 Injector
2.4.2.1.2 Consumables and Accessories
2.4.2.2 By Modality
2.4.2.2.1 CT Injector Systems
2.4.2.2.2 MRI Injector Systems
2.4.2.2.3 Cardiovascular/Angiography Injector Systems
2.4.2.3 By Injector Type
2.4.2.3.1 Single-Head Injectors
2.4.2.3.2 Dual-Head Injectors
2.4.2.3.3 Syringeless Injectors

3 Region

3.1 Overview
3.2 North America
3.2.1 Key Findings
3.2.2 Market Dynamics
3.2.3 Impact Analysis
3.2.4 Market Sizing and Forecast
3.2.4.1 North America Contrast Media Agent and Injector System Market (by Product)
3.2.4.1.1 North America Contrast Media Injector System Market (by Product)
3.2.4.2 North America Contrast Media Agent and Injector System Market (by Country)
3.2.4.2.1 U.S.
3.2.4.2.1.1 Market Sizing and Forecast
3.2.4.2.1.1.1 U.S. Contrast Media Agent and Injector System Market (by Product)
3.2.4.2.1.1.1.1 U.S. Contrast Media Injector System Market (by Product)
3.2.4.2.2 Canada
3.2.4.2.2.1 Market Sizing and Forecast
3.2.4.2.2.1.1 Canada Contrast Media Agent and Injector System Market (by Product)
3.2.4.2.2.1.1.1 Canada Contrast Media Injector System Market (by Product)
3.3 Europe
3.3.1 Key Findings
3.3.2 Market Dynamics
3.3.2.1 Impact Analysis
3.3.3 Market Size and Forecast
3.3.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
3.3.3.1.1 Europe Contrast Media Injector System Market (by Product)
3.3.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
3.3.3.2.1 Germany
3.3.3.2.1.1 Market Sizing and Forecast
3.3.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
3.3.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
3.3.3.2.2 Italy
3.3.3.2.2.1 Market Sizing and Forecast
3.3.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
3.3.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
3.3.3.2.3 France
3.3.3.2.3.1 Market Sizing and Forecast
3.3.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
3.3.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
3.3.3.2.4 U.K.
3.3.3.2.4.1 Market Sizing and Forecast
3.3.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
3.3.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
3.3.3.2.5 Spain
3.3.3.2.5.1 Market Sizing and Forecast
3.3.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
3.3.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
3.3.3.2.6 Rest-of-Europe
3.3.3.2.6.1 Market Sizing and Forecast
3.3.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
3.3.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)
3.4 Asia-Pacific
3.4.1 Key Findings
3.4.2 Market Dynamics
3.4.2.1 Impact Analysis
3.4.3 Market Size and Forecast
3.4.3.1 Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
3.4.3.1.1 Asia-Pacific Contrast Media Injector System Market (by Product)
3.4.3.2 Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
3.4.3.2.1 China
3.4.3.2.1.1 Market Sizing and Forecast
3.4.3.2.1.1.1 China Contrast Media Agent and Injector System Market (by Product)
3.4.3.2.1.1.1.1 China Contrast Media Injector System Market (by Product)
3.4.3.2.2 Japan
3.4.3.2.2.1 Market Sizing and Forecast
3.4.3.2.2.1.1 Japan Contrast Media Agent and Injector System Market (by Product)
3.4.3.2.2.1.1.1 Japan Contrast Media Injector System Market (by Product)
3.4.3.2.3 India
3.4.3.2.3.1 Market Sizing and Forecast
3.4.3.2.3.1.1 India Contrast Media Agent and Injector System Market (by Product)
3.4.3.2.3.1.1.1 India Contrast Media Injector System Market (by Product)
3.4.3.2.4 Australia
3.4.3.2.4.1 Market Sizing and Forecast
3.4.3.2.4.1.1 Australia Contrast Media Agent and Injector System Market (by Product)
3.4.3.2.4.1.1.1 Australia Contrast Media Injector System Market (by Product)
3.4.3.2.5 Rest-of-Asia-Pacific
3.4.3.2.5.1 Market Sizing and Forecast
3.4.3.2.5.1.1 Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
3.4.3.2.5.1.1.1 Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)
3.5 Rest-of-the-World
3.5.1 Key Findings
3.5.2 Market Dynamics
3.5.2.1 Impact Analysis
3.5.3 Market Size and Forecast
3.5.3.1 Rest-of-the-World Contrast Media Agent and Injector System Market (by Product)
3.5.3.2 Rest-of-the-World Contrast Media Injector System Market (by Product)

4 Markets - Competitive Benchmarking & Company Profiles

4.1 Competitive Benchmarking
4.1.1 Key Strategies and Development
4.1.1.1 Regulatory and Legal Activities
4.1.1.2 Partnerships, Collaborations, and Business Expansions
4.1.1.3 Mergers and Acquisitions
4.1.1.4 New Offerings
4.1.2 Market Share Analysis
4.1.2.1 Market Share Analysis, by Contrast Media Agent Market
4.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
4.2 Contrast Media Ecosystem Active Players
4.3 Company Profiles
4.3.1 Bayer AG
4.3.1.1 Company Overview
4.3.1.2 Role of Bayer AG in the Global Contrast Media Agent and Injector System Market
4.3.1.3 Financials
4.3.1.4 Recent Developments
4.3.1.5 Analyst Perception
4.3.2 Beijing Beilu Pharmaceutical Co. Ltd.
4.3.2.1 Company Overview
4.3.2.2 Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Global Contrast Media Agent and Injector System Market
4.3.2.3 Recent Developments
4.3.2.4 Analyst Perception
4.3.3 Bracco Group
4.3.3.1 Company Overview
4.3.3.2 Role of Bracco Group in the Global Contrast Media Agent and Injector System Market
4.3.3.3 Recent Developments
4.3.3.4 Analyst Perception
4.3.4 Fresenius SE & Co. KGaA
4.3.4.1 Company Overview
4.3.4.2 Role of Fresenius SE & Co. KGaA in the Global Contrast Media Agent and Injector System Market
4.3.4.3 Financials
4.3.4.4 Recent Developments
4.3.4.5 Analyst Perception
4.3.5 FUJIFILM Holdings Corporation
4.3.5.1 Company Overview
4.3.5.2 Role of FUJIFILM Holdings Corporation in the Global Contrast Media Agent and Injector System Market
4.3.5.3 Financials
4.3.5.4 Analyst Perception
4.3.6 General Electric Company
4.3.6.1 Company Overview
4.3.6.2 Role of General Electric Company in the Global Contrast Media Agent and Injector System Market
4.3.6.3 Financials
4.3.6.4 Recent Developments
4.3.6.5 Analyst Perspective
4.3.7 Guerbet
4.3.7.1 Company Overview
4.3.7.2 Role of Guerbet in the Global Contrast Media Agent and Injector System Market
4.3.7.3 Financials
4.3.7.4 Recent Developments
4.3.7.5 Analyst Perception
4.3.8 Jiangsu Hengrui Pharmaceutical Co., Ltd.
4.3.8.1 Company Overview
4.3.8.2 Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Global Contrast Media Agent and Injector System Market
4.3.8.3 Recent Developments
4.3.8.4 Analyst Perception
4.3.9 Jodas Expoim Pvt. Ltd.
4.3.9.1 Company Overview
4.3.9.2 Role of Jodas Expoim Pvt. Ltd. in the Global Contrast Media Agent and Injector System Market
4.3.9.3 Analyst Perception
4.3.10 Lantheus Holdings, Inc.
4.3.10.1 Company Overview
4.3.10.2 Role of Lantheus Holdings, Inc. in the Global Contrast Media Agent and Injector System Market
4.3.10.3 Financials
4.3.10.4 Recent Developments
4.3.10.5 Analyst Perspective
4.3.11 Shenzen Seacrown Electromechanical Co., Ltd.
4.3.11.1 Company Overview
4.3.11.2 Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Global Contrast Media Agent and Injector System Market
4.3.11.3 Recent Developments
4.3.11.4 Analyst Perception
4.3.12 Sino Medical-Device Technology Co., Ltd.
4.3.12.1 Company Overview
4.3.12.2 Role of Sino Medical-Device Technology Co., Ltd. in the Global Contrast Media Agent and Injector System Market
4.3.12.3 Analyst Perception
4.3.13 ulrich GmbH & Co. KG
4.3.13.1 Company Overview
4.3.13.2 Role of ulrich GmbH & Co. KG in the Global Contrast Media Agent and Injector System Market
4.3.13.3 Recent Developments
4.3.13.4 Analyst Perception
4.3.14 Unijules Life Sciences Ltd.
4.3.14.1 Company Overview
4.3.14.2 Role of Unijules Life Sciences Ltd. in the Global Contrast Media Agent and Injector System Market
4.3.14.3 Analyst Perception

List of Figures

Figure 1: Global Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 2: Global Contrast Media Agent and Injector System Market, Impact Analysis
Figure 3: Global Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
Figure 4: Global Contrast Media Agent and Injector System Market (by Region), $Million, 2021 and 2026
Figure 5: Global Contrast Media Agent and Injector System Market Segmentation
Figure 6: Global Contrast Media Agent and Injector System Market: Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
Figure 9: Top-Down Approach (Segment-Wise Analysis)
Figure 10: Global Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
Figure 11: Global Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
Figure 12: Number of CT Scans Per One Million Inhabitants in the U.S., 2015, 2017, and 2019
Figure 13: Number of CT Scans Per One Million Inhabitants in Europe (by Country), 2015, 2017, and 2019
Figure 14: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
Figure 15: Number of CT Scans Per One Million Inhabitants, 2018-2020
Figure 16: Number of Scans by Imaging Modalities in the U.K. from 2018-2019 to 2020-2021, Million
Figure 17: Global Contrast Media Agent and Injector System Market, Impact Analysis
Figure 18: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
Figure 19: Global Incidence of Cardiovascular Disease, 2015 - 2019, Million
Figure 20: Innovative Vendors Product Solutions
Figure 21: Global Contrast Media Agent and Injector System Market (by Product)
Figure 22: Global Contrast Media Agent and Injector System Market, Incremental Opportunity, (by Product), $Million, 2022-2026
Figure 23: Global Contrast Media Agent and Injector System Market, Growth-Share Matrix (by Product), 2022-2026
Figure 24: Global Contrast Media Agent Market, $Million, 2021-2026
Figure 25: Global Contrast Media Agent Market (X-Ray/CT Scan), $Million, 2021-2026
Figure 26: Global Contrast Media Agent Market (MRI), $Million, 2021-2026
Figure 27: Global Contrast Media Agent Market (Ultrasound), $Million, 2021-2026
Figure 28: Global Contrast Media Agent Market (Iodine-Based Contrast Media Agent), $Million, 2021-2026
Figure 29: Global Contrast Media Agent Market (Gadolinium-Based Contrast Media Agent), $Million, 2021-2026
Figure 30: Global Contrast Media Agent Market (Barium-Based Contrast Media Agent), $Million, 2021-2026
Figure 31: Global Contrast Media Agent Market (Microbubble Contrast Media Agent), $Million, 2021-2026
Figure 32: Global Contrast Media Agent Market (Others), $Million, 2021-2026
Figure 33: Global Contrast Media Injector System Market, $Million, 2021-2026
Figure 34: Global Contrast Media Injector System Market (Injector), $Million, 2021-2026
Figure 35: Global Contrast Media Injector Systems Market (Consumables and Accessories), $Million, 2021-2026
Figure 36: Global Contrast Media CT Injector System Market by Product, $Million, 2021-2026
Figure 37: Global Contrast Media MRI Injector System Market, by Product, $Million, 2021-2026
Figure 38: Global Contrast Media Cardiovascular/Angiography Injector System Market, by Product, $Million, 2021-2026
Figure 39: Global Contrast Media Injector System Market (Single-Head Injectors), $Million, 2021-2026
Figure 40: Global Contrast Media Injector System Market (Dual-Head Injectors), $Million, 2021-2026
Figure 41: Global Contrast Media Injector System Market (Syringeless Injectors), $Million, 2021-2026
Figure 42: Global Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
Figure 43: North America Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 44: North America Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 45: North America Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 46: North America Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
Figure 47: U.S. Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 48: U.S. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 49: U.S. Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 50: Canada Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 51: Canada Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 52: Canada Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 53: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 54: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 55: Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 56: Europe Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
Figure 57: Germany Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 58: Germany Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 59: Germany Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 60: Italy Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 61: Italy Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 62: Italy Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 63: France Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 64: France Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 65: France Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 66: Number of Scans by Imaging Modalities in the U.K. from 2015-2016 to 2020-2021, Million
Figure 67: U.K. Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 68: U.K. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 69: U.K. Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 70: Number of CT Scanners in Spain per One Million Inhabitants, 2014-2020
Figure 71: Spain Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 72: Spain Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 73: Spain Contrast Media and Injector System Market (by Product), $Million, 2021-2026
Figure 74: Rest-of-Europe Contrast Media Agent and Injector System Market, $Million, 2022-2026
Figure 75: Rest-of-Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 76: Rest-of-Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 77: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 78: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 79: Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 80: Asia-Pacific Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
Figure 81: China Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 82: China Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 83: China Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 84: Japan Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 85: Japan Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 86: Japan Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 87: India Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 88: India Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 89: India Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 90: Australia Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 91: Australia Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 92: Australia Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 93: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 94: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 95: Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 96: Rest-of-the-World Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 97: Rest-of-the-World Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 98: Rest-of-the-World Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 99: Global Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
Figure 100: Regulatory and Legal Activities, January 2018-May 2023
Figure 101: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
Figure 102: Mergers and Acquisitions, January 2018-May 2023
Figure 103: New Offerings, January 2018-May 2023
Figure 104: Global Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
Figure 105: Global Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
Figure 106: Bayer AG: Product Portfolio
Figure 107: Bayer AG: Overall Financials, $Million, 2020-2022
Figure 108: Bayer AG: Net Revenue (by Segment), $Million, 2020-2022
Figure 109: Bayer AG: Net Revenue (by Region), $Million, 2020-2022
Figure 110: Bayer AG: R&D Expenditure, $Million, 2020-2022
Figure 111: Beijing Beilu Pharmaceutical Co. Ltd.: Product Portfolio
Figure 112: Bracco Group: Product Portfolio
Figure 113: Fresenius SE & Co. KGaA: Product Portfolio
Figure 114: Fresenius SE & Co. KGaA: Overall Financials, $Million, 2020-2022
Figure 115: Fresenius SE & Co. KGaA: Net Revenue (by Region), $Million, 2020-2022
Figure 116: Fresenius SE & Co. KGaA: R&D Expenditure, $Million, 2020-2022
Figure 117: FUJIFILM Holdings Corporation: Overall Product Portfolio
Figure 118: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2020-2022
Figure 119: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2022
Figure 120: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2020-2022
Figure 121: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2020-2022
Figure 122: General Electric Company: Product Portfolio
Figure 123: General Electric Company: Overall Financials, $Million, 2020-2022
Figure 124: General Electric Company: Net Revenue (by Segment), $Million, 2020-2022
Figure 125: General Electric Company: Net Revenue (by Region), $Million, 2020-2022
Figure 126: General Electric Company: R&D Expenditure, $Million, 2020-2022
Figure 127: Guerbet: Product Portfolio
Figure 128: Guerbet: Overall Financials, $Million, 2020-2022
Figure 129: Guerbet: Net Revenue (by Segment), $Million, 2020-2022
Figure 130: Jiangsu Hengrui Pharmaceutical Co., Ltd.: Product Portfolio
Figure 131: Jodas Expoim Pvt. Ltd.: Product Portfolio
Figure 132: Lantheus Holdings, Inc.: Product Portfolio
Figure 133: Lantheus Holdings, Inc.: Overall Financials, $Million, 2020-2022
Figure 134: Lantheus Holdings, Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 135: Lantheus Holdings, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 136: Shenzen Seacrown Electromechanical Co., Ltd.: Product Portfolio
Figure 137: Sino Medical-Device Technology Co., Ltd.: Product Portfolio
Figure 138: ulrich GmbH & Co. KG: Product Portfolio
Figure 139: Unijules Life Sciences Ltd.: Product Portfolio

List of Tables

Table 1: Global Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
Table 2: Key Questions Answered in the Report
Table 3: Global Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
Table 5: Some of the Contrast Media Reactions and Effects
Table 6: Guidelines for Contrast Administration and Hydration
Table 7: Contrast Media Agent Market (CT Injector Systems)
Table 8: North America Contrast Media Agent and Injector System Market, Impact Analysis
Table 9: Europe Contrast Media Agent and Injector System Market, Impact Analysis
Table 10: Asia-Pacific Contrast Media Agent and Injector System Market, Impact Analysis
Table 11: Rest-of-the-World Contrast Media Agent and Injector System Market, Impact Analysis
Table 12: Contrast Media Ecosystem Active Players

Samples

LOADING...

Companies Mentioned

Bayer AG
Beijing Beilu Pharmaceutical Co. Ltd.
Bracco Group
Fresenius SE & Co. KGaA
FUJIFILM Holdings Corporation
General Electric Company
Guerbet
Jiangsu Hengrui Pharmaceutical Co. Ltd.
Jodas Expoim Pvt. Ltd.
Lantheus Holdings, Inc.
Shenzen Seacrown Electromechanical Co. Ltd.
Sino Medical-Device Technology Co. Ltd.
ulrich GmbH & Co. KG
Unijules Life Sciences Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	June 2023
Forecast Period	2022 - 2026
Estimated Market Value ( USD ) in 2022	$ 7.63 Billion
Forecasted Market Value ( USD ) by 2026	$ 9.71 Billion
Compound Annual Growth Rate	6.2%
Regions Covered	Global
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€5400EUR$5,500USD£4,490GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€8345EUR$8,500USD£6,940GBP